Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-12-12
2006-12-12
Salimi, Ali R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S005000
Reexamination Certificate
active
07148012
ABSTRACT:
A therapeutic agent for fibromyalgia containing an extract from inflamed tissue inoculated with vaccinia virus as an active ingredient, use of the extract from inflamed tissue inoculated with vaccinia virus as the active ingredient for producing a medicinal composition for treating fibromyalgia, and a method of treating fibromyalgia which comprises administering a medicinal composition containing the extract from inflamed tissue inoculated with vaccinia virus as the active ingredient to a patient. The therapeutic agent containing the extract from inflamed tissue inoculated with vaccinia virus as the active ingredient is a novel therapeutic agent for fibromyalgia, no efficacious therapeutic agent for which has been known heretofore. Moreover, it is very useful as an effective drug having high safety with scarcely any side effects.
REFERENCES:
patent: 5057324 (1991-10-01), Shibayama et al.
patent: 6165515 (2000-12-01), Matsuyama et al.
patent: 0 348 353 (1989-12-01), None
patent: 0 645142 (1995-03-01), None
patent: 0 852 950 (1998-07-01), None
patent: 0 916 344 (1999-05-01), None
patent: 0 953 352 (1999-11-01), None
patent: 1 038 529 (2000-09-01), None
patent: A 53-101515 (1978-09-01), None
patent: A 55-87724 (1980-07-01), None
patent: B 63-39572 (1988-08-01), None
patent: A 1-265028 (1989-10-01), None
patent: A 1-319422 (1989-12-01), None
patent: A 2-28119 (1990-01-01), None
patent: A 7-97336 (1995-04-01), None
patent: A 8-291077 (1996-11-01), None
patent: B 2594222 (1996-12-01), None
patent: A 10-194978 (1998-07-01), None
patent: A 11-80005 (1999-03-01), None
patent: A 11-139977 (1999-05-01), None
patent: A 2000-16942 (2000-01-01), None
patent: A 2000-336034 (2000-12-01), None
patent: A 2001-58950 (2001-03-01), None
patent: WO 01/68643 (2001-09-01), None
Matsuoka et al, Nippon Yakurigaku Zasshi, 1987, vol. 90, No. 1, pp. 67-71, abstract only.
Yoshi et al, Int. J. Immunopharmacology, 1995, vol. 17, No. 11, pp. 879-886.
“Drugs in Japan”, ethical Drugs[(25thedition), edited by Japan Pharmaceutical Information Center: published by Jino, Inc. (2002)], pp. 2379-2381, with concise explanation.
“Rheumatism”, Apr. 2003, vol. 4, No. 2, p. 331, W 51-6-O/P, with translation.
Argenes, Inc.
Nippon Zoki Pharmaceutical Co. Ltd.
Oliff & Berridg,e PLC
Salimi Ali R.
LandOfFree
Therapeutic agent for fibromyalgia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for fibromyalgia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for fibromyalgia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3711545